Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus-2 (TEMD-2 Study)

Last updated: April 3, 2024
Sponsor: Gulhane School of Medicine
Overall Status: Completed

Phase

N/A

Condition

Diabetes Prevention

Diabetes And Hypertension

Treatment

There is no intervention.

Clinical Study ID

NCT06347445
GSM012024
  • Ages > 18
  • All Genders

Study Summary

This study evaluates the metabolic control status, cardiovascular risk and frequency of comorbidities in diabetic patients followed in tertiary treatment centers in Turkey.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with type 1 or type 2 diabetes
  • Upper than 18 years old
  • To be under follow-up in the same center for at least one year.

Exclusion

Exclusion Criteria:

  • Pregnant or lactation period
  • Younger than 18 years old
  • History of psychiatric disorders interfering cognition or compliance

Study Design

Total Participants: 5707
Treatment Group(s): 1
Primary Treatment: There is no intervention.
Phase:
Study Start date:
October 01, 2022
Estimated Completion Date:
January 30, 2023

Study Description

Diabetes mellitus is one of the most common chronic diseases worldwide.The prevalence of diabetes is increased significantly in Türkiye, from 7.2 % in 2002 to 13.7% in 2012. This increasing prevalence leads to serious public health problems and a significant economic burden. Many important diseases such as hypertension and dyslipidemia accompany the picture in diabetic patients. The optimal treatment of diabetes and prevention of diabetic complications, especially the cardiovascular outcomes, is utmost important. Although achieving glycemic targets in patients with diabetes is of great importance, blood glucose is not the only predictor of cardiovascular outcome in diabetes. Optimization of other metabolic parameters such as lipids, arterial blood pressure (ABP), and body weight as well as a healthy lifestyle are utmost important.

Common problems in diabetic patients, such as sleep disorders and sexual dysfunction, affect glycemia regulation in these patients.There is little data on the frequency of these diseases in diabetic patients in Türkiye.

In the TEMD-1 study conducted in 2017, the rates of diabetic patients achieving metabolic goals and the factors affecting these rates were revealed in Turkish patients with diabetes. The findings obtained in the current study will be compared with the findings in 2017, and in addition, the frequency of comorbidities such as sleep disorder, sexual dysfunction, and depression will be tried to be revealed.

Connect with a study center

  • Gulhane School of Medicine Department of Endocrinology and Metabolism

    Ankara, 06010
    Turkey

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.